4(S)-(6-Amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol ((subclone P5A) cell lines but were 12 and 11 M for human granulocyte-macrophage (CFU-GM) and erythroid (BFU-E) progenitor cells, respectively. When given orally to rats and mice, the compound was very well absorbed and rapidly eliminated. However, there was no detectable brain penetration by IsoddA in rats. Catabolic metabolites were not detected, and this is consistent with the observed resistance of the compound to metabolic degradation by adenosine deaminase.